Stimate Disease Interactions
There are 4 disease interactions with Stimate (desmopressin).
Desmopressin (applies to Stimate) renal dysfunction
Major Potential Hazard, High plausibility.
The use of desmopressin is contraindicated in patients with moderate to severe renal impairment (defined as a creatinine clearance below 50 mL/min).
Vasopressin/desmopressin (applies to Stimate) fluid overload/hyponatremia
Major Potential Hazard, High plausibility. Applicable conditions: Fluid Retention, Seizures, Congestive Heart Failure, Migraine, Asthma
Water intoxication and hyponatremia may occur during therapy with vasopressin or desmopressin due to their antidiuretic action. Patients are most likely to experience this problem if their fluid intake is excessive or if they do not require antidiuresis, such as when they are administered these agents for their hemostatic effects. Fluid intake should be adjusted carefully to avoid overhydration, particularly in children, elderly, and patients with conditions that may be exacerbated by fluid retention, including epilepsy, migraine, asthma, and heart failure. Patients should be monitored for signs of water intoxication (e.g., listlessness, drowsiness, and headaches), which may rarely progress to seizures and coma. The use of desmopressin is contraindicated in patients with hyponatremia or a history of hyponatremia.
Desmopressin (applies to Stimate) thrombotic events
Moderate Potential Hazard, Low plausibility. Applicable conditions: Thrombotic/Thromboembolic Disorder, History - Thrombotic/Thromboembolic Disorder
Rare cases of thrombotic events (thrombosis, acute cerebrovascular thrombosis, and acute myocardial infarction) have been reported following desmopressin injection in patients predisposed to thrombus formation. Although a causal relationship has not been established, therapy with desmopressin should be administered cautiously in patients with a current or past history of thrombotic or thromboembolic disorders.
Desmopressin (applies to Stimate) vascular disease
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Ischemic Heart Disease, Hypertension
The use of desmopressin, primarily in parenteral administration and/or in large doses, has been infrequently associated with changes in blood pressure, causing either slight elevations or transient decreases with a compensatory increase in heart rate. Therapy with desmopressin, regardless of route of administration, should be administered cautiously in patients with coronary artery insufficiency and/or hypertensive cardiovascular disease.
Switch to professional interaction data
Stimate drug interactions
There are 122 drug interactions with Stimate (desmopressin).
Stimate alcohol/food interactions
There are 2 alcohol/food interactions with Stimate (desmopressin).
More about Stimate (desmopressin)
- Stimate consumer information
- Check interactions
- Compare alternatives
- Reviews (4)
- Latest FDA alerts (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antidiuretic hormones
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Vonvendi
Vonvendi (von Willebrand factor (recombinant)) is used to treat bleeding episodes in adults with ...
Lysteda
Lysteda (tranexamic acid) is used to treat heavy menstrual bleeding. Includes Lysteda side effects ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Hemlibra
Hemlibra is a monoclonal antibody that functions in place of a natural blood-clotting factor that ...
DDAVP
DDAVP is used for diabetes insipidus, hemophilia a, primary nocturnal enuresis, von Willebrand Disease
Qfitlia
Qfitlia is used for hemophilia a, hemophilia a with inhibitors, hemophilia b, hemophilia b with ...
Altuviiio
Altuviiio is a once-weekly recombinant fact VIII replacement therapy used by hemophilia A patients ...
Cyklokapron
Cyklokapron is used for bleeding disorder, factor ix deficiency, hemophilia a
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.